26 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
pandemic and macroeconomic factors that could impact our business, such as supply chain and inflationary pressures and the effects of the Russian … , interruptions or other adverse
effects to clinical trials and patient enrollment; delays in regulatory review; manufacturing and supply chain interruptions
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
, quality systems, manufacturing, supply chain, product development, formulation, and IT. From 2009 to 2011, Mr. Le was the Chief Operating Officer
DEFM14A
5l6btm om8bg
24 Jun 22
Proxy related to merger
4:44pm
424B3
00hzeulno0q6k7i
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
82hgvro
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
cpx2o69t1 vy
13 May 22
Registration of securities issued in business combination transactions
5:10pm
424B5
d21nt9
23 Jun 21
Prospectus supplement for primary offering
12:26pm
424B5
1vrntbic
22 Jun 21
Prospectus supplement for primary offering
5:23pm
424B3
ruvafay42vse3
28 Apr 21
Prospectus supplement
9:49pm